CD44 and adenocarcinoma: We recently demonstrated that the subpopulation of human colorectal tumor cells with an ESA+CD44+ phenotype is uniquely responsible for generating heterogeneous adenocarcinomas in a xenograft setting (Figure 1A & B)[30].